The World Health Organization (WHO) has issued the latest in a string of alerts concerning subpar medications coming from India, this time regarding a batch of common cold syrup made by an Indian business.

The WHO stated on Monday that the producer and marketer had not given assurances on the product’s quality and safety.

The syrup, known by the brand name Cold Out, was made by Fourrts (India) Laboratories for Dabilife Pharma, according to the United Nations agency, and it was found in Iraq in a batch that exceeded permitted limits for the pollutants diethylene and ethylene glycol.

According to WHO, the batch had 2.1% of ethylene glycol and 0.25% of diethylene glycol, both of which were above the recommended safety level of 0.10%.

The warning regarding Cold Out is the most recent one regarding tainted cough syrups that are distributed all over the world in recent months. At least five of the syrups under investigation are made by Indian companies.

Indian cough syrups were blamed for at least 89 child fatalities in the Gambia and Uzbekistan last year.